Therapeutic Group: Monoclonal Antibody Presentation Advixa 40: Each pre-filled syringe contains 0.8 ml sterile solution of Adalimumab 40 mg. Description Adalimumab is a recombinant human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF). Adalimumab binds specifically to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also […]
Therapeutic Group: Acidifier Presentation Synergistic blend of free and highly buffered organic acids Description Selko -pH is a synergistic blend of free and highly buffered organic acids. The synergistic blend organic acid effectively reduces pH of drinking water and the stomach and helps in feed digestion. Buffered organic acids help to maintain a healthy microbial […]
Therapeutic Group: Anti Viral Presentation Simplovir 200 tablet: Each tablet contains Aciclovir BP 200 mg. Simplovir 400 tablet: Each tablet contains Aciclovir BP 400 mg. Simplovir 250 IV: Each vial contains lyophilized powder of Aciclovir Sodium equivalent to Aciclovir BP 250 mg. Simplovir 500 IV: Each vial contains lyophilized powder of Aciclovir Sodium equivalent to […]
Therapeutic Group: Analgesic, Anti Inflammatory Presentation Reservix : Each film-coated tablet contains Aceclofenac BP 100 mg. Reservix SR: Each film-coated sustained release tablet contains Aceclofenac BP 200 mg. Description Reservix is a non-steroidal agent with antiinflammatory and analgesic properties. Its mode of action is largely based on inhibition of prostaglandin synthesis. Reservix is a potent […]
Therapeutic Group: Anti Cancer Presentation Calcent 100: Each capsule contains Acalabrutinib INN 100 mg. Description Acalabrutinib is a small-molecule inhibitor of BTK. Acalabrutinib and its active metabolite, ACP-5862, form a covalent bond with a cysteine residue in the BTK active site, leading to inhibition of BTK enzymatic activity. BTK is a signaling molecule of the […]
Therapeutic Group: Suture Presentation Absorbable Synthetic Multifilament, Polyglactin 910 (Violet) Description Coated Polysoft (polyglactin 910) is a synthetic absorbable sterile surgical suture, composed of a copolymer made from 90% glycolide and 10% L-lactide. This suture is prepared by coating the suture material with a mixture composed of equal parts of copolymer of glycolide and lactide […]
Therapeutic Group: Suture Presentation Absorbable Synthetic Multifilament, Polyglactin 910 (Violet) Description Coated Polysoft (polyglactin 910) is a synthetic absorbable sterile surgical suture, composed of a copolymer made from 90% glycolide and 10% L-lactide. This suture is prepared by coating the suture material with a mixture composed of equal parts of copolymer of glycolide and lactide […]
Therapeutic Group: Suture Presentation Absorbable Synthetic Multifilament, Polyglactin 910 (Violet) Description Coated Polysoft (polyglactin 910) is a synthetic absorbable sterile surgical suture, composed of a copolymer made from 90% glycolide and 10% L-lactide. This suture is prepared by coating the suture material with a mixture composed of equal parts of copolymer of glycolide and lactide […]
Therapeutic Group: Others Presentation Coated Polysoft Anti-B (Polyglactin 910 Antibacterial) is a synthetic absorbable sterile surgical suture, composed of a copolymer made from 90% glycolide and 10% L-lactide. This suture is coated with a mixture composed of equal parts of a copolymer of glycolide and lactide (Polyglactin 370) and calcium stearate. The suture contains Irgacare […]
Therapeutic Group: Others Presentation Coated Polysoft suture elicits a minimal acute inflammatory reaction in tissue and ingrowth of fibrous connective tissue. Progressive loss of tensile strength and eventual absorption of this suture occurs by means of hydrolysis where the copolymer degrades to glycolic and lactic acids which are subsequently absorbed and metabolized in the body. […]